Grown Rogue International (GRUSF) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Grown Rogue International (GRUSF) Interest Coverage Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.94% |
| Mar 31, 2026 | -97.84% |
| Sep 30, 2025 | -41,580,904.85% |
| Jun 30, 2025 | 346,449,238,728,738.75% |
| Mar 31, 2025 | 157.93% |
| Jan 31, 2023 | -53.17% |
| Jan 31, 2022 | -103.67% |
| Jul 31, 2021 | -303.99% |
| Apr 30, 2021 | 103.80% |
| Jan 31, 2021 | 5,966.87% |
| Oct 31, 2020 | 98.54% |
| Jul 31, 2020 | 149.52% |
| Apr 30, 2020 | 105.46% |
| Jan 31, 2020 | -106.98% |
| Oct 31, 2019 | -180.25% |
| Jul 31, 2019 | -788.65% |
| Apr 30, 2019 | -4,765.93% |
| Jan 31, 2019 | 862.97% |
| Aug 31, 2018 | -77,202.54% |
| May 31, 2018 | 3,501.95% |